Search - tctmd.com

Displaying 921 - 940 of 1003

Sort: Relevancy | Date

Presentation TCT 2012

Cases 1 and 2: FFR in Acute Coronary Syndromes

Presenter: Habib Samady

October 25, 2012

Presentation TCT 2012

Case 5: FFR in Tandem Lesions

Presenter: Nico Pijls

October 25, 2012

Presentation TCT 2012

Case 4: IFR Case

Presenter: Sayan Sen

October 25, 2012

Presentation TCT 2012

Case 4: FFR in ACS

Presenter: Petr Kala

October 25, 2012

Presentation TCT 2012

Case 3: FFR and Left Main Disease

Presenter: Michalis Hamilos

October 25, 2012

Presentation TCT 2012

Case 2: FFR and Multivessel Disease

Presenter: Pim Tonino

October 25, 2012

Presentation TCT 2012

Case 1: FFR in Bifurcations

Presenter: Bon-Kwon Koo

October 25, 2012

Presentation TCT 2012

Can Any IVUS/OCT Parameters Replace FFR?

Presenter: Bon-Kwon Koo

October 25, 2012

Presentation TCT 2012

Basal Stenosis Resistance Index: Background and Clinical Data

Presenter: Tim van de Hoef

October 25, 2012

Presentation TCT 2012

A Challenge to All Basal Modalities: Why They Can Never Be as Good as Hyperemic Indices

Presenter: Nico Pijls

October 25, 2012

Presentation TCT 2012

Lessons from FAME II

Presenter: Stuart Pocock

October 24, 2012

Presentation TCT 2012

FAME 2 Cost-effectiveness: A Prospective, Randomized Trial Evaluating the Cost-effectiveness of FFR-Guided PCI in Patients with Stable Coronary Artery Disease

Presenter: William Fearon

October 24, 2012

Presentation TCT 2012

Case 2: FFR-Guided Decision Making for Anomalous Origin of RCA

Presenter: Bon-Kwon Koo

October 24, 2012

Presentation TCT 2012

The Case for CT-FFR as the Optimal Screening Tool: Latest DEScover and DeFACTO Results

Presenter: Jonathon Leipsic

October 23, 2012

Presentation TCT 2012

TCT-19. Fractional Flow Reserved Derived from Computed Tomographic Angiography (FFRCT) for Intermediate Severity Coronary Lesions: Results from the DeFACTO Trial...

Presenter: James Min

October 23, 2012

Presentation TCT 2012

TCT-18. Long-term Outcome of Discordance Between Fractional Flow Reserve and Coronary Flow Velocity Reserve After Deferral of Percutaneous Coronary Intervention

Presenter: Tim van de Hoef

October 23, 2012

Presentation TCT 2012

Physiologic Lesion Assessment: Key Clinical Results, Guidelines, and Case Presentations (with Integrated Q&A)

Presenter: Michael Lim

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: ACRIN-PA (CTA in Low-Intermediate Risk Chest Pain) and ROMICAT II (CTA in Low-Intermediate Risk Chest Pain)

Presenter: Issam Mikati

October 23, 2012

Presentation TCT 2012

VERDICT/FIRST: Prospective, Multicenter Study Examining the Correlation between IVUS and FFR Parameters in Intermediate Lesions

Presenter: Gregg Stone

October 22, 2012

Presentation TCT 2012

Uses and Utility of FFR During Bifurcation Stenting

Presenter: Bon-Kwon Koo

October 22, 2012

Advertisement

Cases 1 and 2: FFR in Acute Coronary Syndromes

Case 5: FFR in Tandem Lesions

Case 4: IFR Case

Case 4: FFR in ACS

Case 3: FFR and Left Main Disease

Case 2: FFR and Multivessel Disease

Case 1: FFR in Bifurcations

Can Any IVUS/OCT Parameters Replace FFR?

Basal Stenosis Resistance Index: Background and Clinical Data

A Challenge to All Basal Modalities: Why They Can Never Be as Good as Hyperemic Indices

Lessons from FAME II

FAME 2 Cost-effectiveness: A Prospective, Randomized Trial Evaluating the Cost-effectiveness of FFR-Guided PCI in Patients with Stable Coronary Artery Disease

Case 2: FFR-Guided Decision Making for Anomalous Origin of RCA

The Case for CT-FFR as the Optimal Screening Tool: Latest DEScover and DeFACTO Results

TCT-19. Fractional Flow Reserved Derived from Computed Tomographic Angiography (FFRCT) for Intermediate Severity Coronary Lesions: Results from the DeFACTO Trial...

TCT-18. Long-term Outcome of Discordance Between Fractional Flow Reserve and Coronary Flow Velocity Reserve After Deferral of Percutaneous Coronary Intervention

Physiologic Lesion Assessment: Key Clinical Results, Guidelines, and Case Presentations (with Integrated Q&A)

Late Breaking Clinical Trials: ACRIN-PA (CTA in Low-Intermediate Risk Chest Pain) and ROMICAT II (CTA in Low-Intermediate Risk Chest Pain)

VERDICT/FIRST: Prospective, Multicenter Study Examining the Correlation between IVUS and FFR Parameters in Intermediate Lesions

Uses and Utility of FFR During Bifurcation Stenting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content